Blair William & CO Curis Inc Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $44,500 - $80,900	-10,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.45 - $16.27 $74,500 - $162,700	10,000 New	10,000 $81,000
Q1 2021 May 13, 2021	SELL	$8.78 - $12.8 $87,800 - $128,000	-10,000 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$1.08 - $8.2 $10,800 - $82,000	10,000 New	10,000 $82,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.